Company / SG&A Expense
TransMedics Group, Inc. SG&A Expense History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest SG&A Expense
$185.2M
FY2025
5-year range
$38.3M / $185.2M
FY2021-FY2025
Trend
+9.8%
vs FY2024
Sector context
#107 of 152
Health Care
What the data says
At $185M, TransMedics Group, Inc.'s sg&a expense ranks #46 of 152 in the Health Care sector. SG&A Expense has increased for 7 consecutive years, from $12M in FY2018 to $185M in FY2025.
Based on SEC 10-K filings.
$185M in FY2025 with a 5-year CAGR of +50.2%.
Increased from $120M to $185M over the past 2 years.
Health Care sector context is included.
SG&A Expense over time
Growth rates
- 3-Year CAGR
- +38.4%
- 5-Year CAGR
- +50.2%
- 10-Year CAGR
- -
Sector benchmark
#46 of 152 in Health CareTop 30% of 152This company $185.2M Sector average $182.7B
▼
-99.9% below sector average
Key checks
Key Insights
- TransMedics Group, Inc.'s sg&a expense has grown for 7 consecutive years.
- 5-year CAGR of +50.2%, indicating consistent growth.
- In FY2025, sg&a expense increased 9.8% year-over-year.
- Ranks #107 out of 152 companies in the Health Care sector.
Annual data
| Year | SG&A ExpenseValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $185.2M | +9.8% |
| FY2024 | $168.6M | +41.0% |
| FY2023 | $119.6M | +71.0% |
| FY2022 | $69.9M | +82.6% |
| FY2021 | $38.3M | +58.3% |
| FY2020 | $24.2M | +2.5% |
| FY2019 | $23.6M | +91.6% |
| FY2018 | $12.3M | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026